Effect of dyslipidemia on HBsAg clearance in nucleos(t)ide analogues-experienced chronic hepatitis B patients treated with peginterferon alfa

Abstract Background While previous reports have shown that hepatitis B virus (HBV) infection affects lipid metabolism and vice versa, the impact of dyslipidemia on the functional cure of HBV infection following peginterferon alfa (PegIFNα) therapy remains unknown. Hence, this study aimed to investig...

Descripción completa

Detalles Bibliográficos

Autores principales:	Kaimin Song, Lan Ren, Yunyun Qian, Huitong Wang, Zhixiang Guo, Huatang Zhang, Yijie Lin, Yijuan Zheng, Dawu Zeng, Yongjun Zhou, Zhijun Su, Xueping Yu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2024-11-01
Colección:	BMC Infectious Diseases
Materias:	Chronic hepatitis B Hepatitis B surface Antigen Peginterferon Alfa Dyslipidemia Nomogram
Acceso en línea:	https://doi.org/10.1186/s12879-024-10093-w
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!